The Times Australia
PR Newswire

.

Nintex Acquires eSignature Leader AssureSign

Nintex Acquires eSignature Leader AssureSign

Company's latest technology acquisition brings native eSignature capabilities to the Nintex Process Platform to offer complete end-to-end automation for organisations that leverage Nintex to accelerate their digital transformation

AUCKLAND, New Zealand, June 3, 2021 /PRNewswire/ -- Nintex, the global standard for process management and automation, today announced the company has acquired AssureSign, an electronic signature pioneer and leading digital transaction management (DTM) software provider, to meet customer demand for a native eSignature capability within the Nintex Process Platform.

"We are excited to welcome eSignature leader AssureSign and its customers to our burgeoning Nintex community," said Nintex CEO Eric Johnson. "AssureSign's automation technologies, like with our previous acquisitions, are well architected and will be integrated within the Nintex Process Platform over the months ahead to bring powerful and easy-to-use digital signatures to every organisation that is leveraging Nintex to improve the way people work."

With the Nintex Process Platform, public and private sector organisations across every major industry are enhancing the customer experience, saving costs and improving operations by visually mapping and managing business processes with Nintex Promapp® and accelerating digital transformation with mobile apps, digital forms, workflows, robotic process automation (RPA), DocGen® and eSignatures.

"On behalf of the entire AssureSign team, we are thrilled to make eSignatures a critical part of Nintex's market-leading process management and automation platform," said AssureSign CEO David Brinkman. "Our cultures are both perfectly centered around our combined passion for customer success and we look forward to rapidly integrating AssureSign's eSignatures with Nintex's digital workflows and forms, document automation, and more."

AssureSign serves over 100,000 active monthly users in a variety of areas including regulated industries like insurance and financial services. The company boasts more than 500 customers, executing more than 800 million eSignatures worldwide since its founding. With AssureSign's ease-of-use, flexible API's and eSign via Text, organisations can quickly and securely send documents for signature to any device, at any time, and from anywhere via customised experiences.

"Nintex is laser-focused on executing its growth strategy and solidifying its position as a leading digital business platform," said Aragon CEO and Lead Analyst Jim Lundy. "The choice to acquire AssureSign brings together two digital transaction management leaders who have deep knowledge of what is required for organisations to remain competitive in today's increasingly automated world."

AssureSign is Nintex's fourth acquisition since Thoma Bravo became the company's majority investor in early 2018. Nintex is one of the world's largest privately held process automation software vendors, serving more than 10,000 customers, including more than 50 percent of the Fortune 500, and generates more than $250 million in annual sales.

Deal terms will not be disclosed. 

Media ContactKristin Treat  kristin.treat@nintex.com[1]  cell: (215) 317-9091 

About NintexNintex is the global standard for process management and automation. Today more than 10,000 public and private sector organisations across 90 countries turn to the Nintex Platform to accelerate progress on their digital transformation journeys by quickly and easily managing, automating and optimising business processes. Learn more by visiting www.nintex.com[2] and experience how Nintex and its global partner network are shaping the future of Intelligent Process Automation (IPA).

Product or service names mentioned herein may be the trademarks of their respective owners.

Logo - https://mma.prnasia.com/media2/700078/Nintex_Logo.jpg?p=medium600[3]

Read more https://www.prnasia.com/story/archive/3394533_EN94533_0

Business Times

How Businesses Turn Data into Actionable Insights

In today's digital landscape, businesses are drowning in data yet thirsting for meaningful direction. The challenge isn't...

Ricoh Launches IM C401F A4 Colour MFP to Boost Speed and Security…

Ricoh, a leading provider of smart workplace technology, today launched the RICOH IM C401F, an enterprise-grade A4 colour d...

Laundrlab Expands with a New Flagship Store, Redefining Sustainab…

DESIGNED TO CALM. BUILT TO LAST. POWERED BY PURPOSE. THE FUTURE OF LAUNDRY STARTS IN POTTS POINT Sydney, N...

The Times Features

What is creatine? What does the science say about its claims to build muscle and boost brain health?

If you’ve walked down the wellness aisle at your local supermarket recently, or scrolled the latest wellness trends on social media, you’ve likely heard about creatine. Creati...

Whole House Water Filters: Essential or Optional for Australian Homes?

Access to clean, safe water is something most Australians take for granted—but the reality can be more complex. Our country’s unique climate, frequent droughts, and occasional ...

How Businesses Turn Data into Actionable Insights

In today's digital landscape, businesses are drowning in data yet thirsting for meaningful direction. The challenge isn't collecting information—it's knowing how to turn data i...

Why Mobile Allied Therapy Services Are Essential in Post-Hospital Recovery

Mobile allied health services matter more than ever under recent NDIA travel funding cuts. A quiet but critical shift is unfolding in Australia’s healthcare landscape. Mobile all...

Sydney Fertility Specialist – Expert IVF Treatment for Your Parenthood Journey

Improving the world with the help of a new child is the most valuable dream of many couples. To the infertile, though, this process can be daunting. It is here that a Sydney Fertil...

Could we one day get vaccinated against the gastro bug norovirus? Here’s where scientists are at

Norovirus is the leading cause[1] of acute gastroenteritis outbreaks worldwide. It’s responsible for roughly one in every five cases[2] of gastro annually. Sometimes dubbed ...